PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 111 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $87,000 | -91.9% | 13,883 | -95.9% | 0.00% | -100.0% |
| Q1 2020 | $1,071,000 | +565.2% | 339,869 | +2051.1% | 0.01% | +1200.0% |
| Q2 2018 | $161,000 | -8.5% | 15,800 | +17.0% | 0.00% | 0.0% |
| Q1 2018 | $176,000 | -97.9% | 13,500 | -96.1% | 0.00% | -97.1% |
| Q2 2017 | $8,435,000 | +9.9% | 350,000 | -12.2% | 0.04% | -2.8% |
| Q1 2017 | $7,678,000 | +99.2% | 398,850 | +59.3% | 0.04% | +71.4% |
| Q4 2016 | $3,855,000 | – | 250,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $33,805,000 | 33.22% |
| Abingworth LLP | 1,041,131 | $13,535,000 | 8.41% |
| Roumell Asset Management, LLC | 197,347 | $2,566,000 | 5.65% |
| Trellus Management Company, LLC | 89,700 | $1,166,000 | 2.12% |
| Prosight Management, LP | 148,682 | $1,933,000 | 1.21% |
| Broadfin Capital, LLC | 477,607 | $6,209,000 | 0.97% |
| HIGHLAND CAPITAL MANAGEMENT LP | 959,278 | $12,471,000 | 0.64% |
| ARMISTICE CAPITAL, LLC | 580,000 | $7,540,000 | 0.58% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,500 | $1,346,000 | 0.52% |
| Opus Point Partners Management, LLC | 20,000 | $260,000 | 0.51% |